Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giovanni Marasco und 10 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Azienda Ospedaliero, Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Gastritis, Enteritis. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Eosinophilic gastrointestinal diseases (EGIDs) are an emerging group of pathological entities characterized by an eosinophil-predominant infiltration of different tracts of the gut in the absence of secondary causes of eosinophilia. According to the specific tract of the gut involved, EGIDs can be classified into eosinophilic esophagitis (EoE), eosinophilic gastritis (EoG), eosinophilic enteritis (EoN), and eosinophilic colitis (EoC). The epidemiology of EGIDs is evolving rapidly. EoE, once considered a rare disease, now has an incidence and prevalence of 7.7 new cases per 100,000 inhabitants per years and 34.4 cases per 100,000 inhabitants per year, respectively. Fewer data are available regarding non-EoE EGIDs, whose prevalence are estimated to range between 2.1 and 17.6 in 100,000 individuals, depending on age, sex, and ethnicity. Diagnosis requires the presence of suggestive symptoms, endoscopic biopsies showing abnormal values of eosinophils infiltrating the gut, and exclusion of secondary causes of eosinophilia. EoE typically presents with dysphagia and episodes of food bolus impactions, while EoG, EoN, and EoC may all present with abdominal pain and diarrhea, with or without other non-specific symptoms. In addition, although different EGIDs are currently classified as different entities, there may be overlap between different diseases in the same patient. Despite EGIDs being relatively novel pathological entities, the research on possible treatments is rapidly growing. In this regard, several randomized controlled trials are currently ongoing to investigate novel molecules, including ad-hoc steroid formulations, immunosuppressants, and mostly monoclonal antibodies that target the specific molecular mediators of EGIDs. This narrative review provides an up-to-date overview of available and investigational drugs for different EGIDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRCCS Azienda Ospedaliero, Universitaria di Bologna, Via Massarenti 9, 40138 Bologna, Italy.
- Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti, 9, 40138 Bologna, Italy.
- Gastroenterology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Via Risorgimento 36, 56126 Pisa, Italy.
- Gastroenterology Unit, Azienda Ospedale Università of Padua, Via Giustiniani 2, 35128 Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology, University of Padua, Via Giustiniani 2, 35128 Padua, Italy.
ORCID-Profile: Giovanni Marasco, Pierfrancesco Visaggi, Nicola De Bortoli, Massimo Bellini, Edoardo Vincenzo Savarino
Zitieren
APA
Marasco, G., Visaggi, P., Vassallo, M., Fiocca, M., Cremon, C., Barbaro, M. R., De Bortoli, N., Bellini, M., Stanghellini, V., Savarino, E. V., & Barbara, G. (2023). Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015165
Vancouver
Marasco G, Visaggi P, Vassallo M, Fiocca M, Cremon C, Barbaro MR, et al. Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015165
BibTeX
@article{Marasco2023,
author = {Marasco, Giovanni and Visaggi, Pierfrancesco and Vassallo, Mariagiulia and Fiocca, Miriam and Cremon, Cesare and Barbaro, Maria Raffaella and De Bortoli, Nicola and Bellini, Massimo and Stanghellini, Vincenzo and Savarino, Edoardo Vincenzo and Barbara, Giovanni},
title = {Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015165}
}
EUVIMED